癌变·畸变·突变 ›› 2022, Vol. 34 ›› Issue (2): 134-138.doi: 10.3969/j.issn.1004-616x.2022.02.011

• 技术与方法 • 上一篇    

镁合金材料慢性毒性与致癌合并试验中分时段采血的必要性研究

刘香东, 赵增琳, 王鸾鸾, 展荣凯, 刘增祥, 吴新宇, 刘成虎   

  1. 山东省医疗器械和药品包装检验研究院, 山东济南 250101
  • 收稿日期:2021-11-18 修回日期:2022-02-24 发布日期:2022-04-07
  • 通讯作者: 刘成虎,E-mail:liuchenghu510@163.com E-mail:liuchenghu510@163.com
  • 作者简介:刘香东,E-mail:liuxiangdongz@163.com。
  • 基金资助:
    山东省医疗器械和药品包装检验研究院项目(ZX201804)

Involvement of blood collections by time in combined chronic toxicity and carcinogenicity test for magnesium alloy materials

LIU Xiangdong, ZHAO Zenglin, WANG Luanluan, ZHAN Rongkai, LIU Zengxiang, WU Xinyu, LIU Chenghu   

  1. Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection, Jinan 250101, Shandong, China
  • Received:2021-11-18 Revised:2022-02-24 Published:2022-04-07

摘要: 目的:以镁合金材料(接骨板)为例,探讨慢性毒性与致癌合并试验中分时段采血的必要性。为建立医疗器械行业慢性毒性与致癌合并试验国家标准提供参考。方法:选取SD大鼠240只,雌雄各半,随机分为对照组和试验组。试验组大鼠皮下植入镁合金材料(接骨板),对照组作假手术处理。在植入后第3、6、12和18个月对两组部分动物进行麻醉、取血,并进行临床病理学检查。将试验组与对照组的血液学指标、血生化指标进行统计学分析。结果:不同时段试验组与对照组相比,血液学、血生化各项指标的差异均无统计学意义(P>0.05)。结论:在进行镁合金材料(接骨板)慢性毒性与致癌合并试验时,在充分了解该材料的情况下,取消分时段取血是可行的。并建议同时增加临床观察频率,使濒死动物能及时取血、解剖,进而保证动物的存活率,以便更好的分析材料对大鼠的慢性毒性作用以及致癌作用。

关键词: 医疗器械, 慢性毒性与致癌合并试验, 分时段采血, 镁合金材料, 接骨板

Abstract: OBJECTIVE:To investigate involvement of blood collections by time in the combined chronic toxicity and carcinogenicity test for magnesium alloy bone plate,and to provide reference for establishment of the national standard for such tests in the field of medical devices. METHODS:160 SD rats (half males and half females) were randomly assigned to the test and the control groups. The test articles were implanted into the subcutaneous tissues and sham operations were conducted to the control rats. The two groups of animals were anesthetized and blood samples were collected during the 3rd,6th,12th and 18th months for clinical pathology analyses. Hematology and clinical chemistry values were analyzed statistically. RESULTS:Compared to the control animals,there were no significant difference in hematology values and clinical chemistry values. CONCLUSION:It is feasible to cancel the blood collection by time when conducting the combined chronic toxicity and carcinogenicity test on medical devices/biomaterials. At the same time, frequencies of clinical observations could be increased so that the dying animals could be taken blood and dissected in time. This would ensure survival rates of animals and better analyses of chronic toxicity and carcinogenic effects of materials on rats.

Key words: medical devices, combined chronic toxicity and carcinogenicity test, blood collection by time, magnesium alloy materials, bone plate

中图分类号: